Study suggests link between long-term estrogen exposure and brain health
A study published in the journal Neurology indicates that extended exposure to estrogen may help preserve brain health and lower markers associated with Alzheimer's disease.
Researchers tracking 352 cognitively unimpaired women over five years found that those with longer lifetime exposure to estrogen—via oral contraceptives or hormone therapy—exhibited fewer physiological markers linked to Alzheimer's disease. The study, published in the journal Neurology, supports the theory that estrogen acts as a neuroprotective agent, aiding in inflammation reduction and blood flow regulation.
Historically, the medical community's view on estrogen therapy was cautious. In 2023, the FDA removed long-standing "black box" warnings from hormone-based therapies for menopause, which had previously deterred many clinicians due to concerns regarding cardiovascular risks. This regulatory shift has prompted a broader reassessment of hormone replacement therapy’s role in managing both immediate symptoms and long-term cognitive health.
The findings arrive amid a notable rise in demand for hormone-based treatments, leading to localized shortages of estrogen patches. While the study clarifies the protective role of both endogenous and exogenous estrogen, researchers note that the abrupt loss of the hormone remains a potential factor in accelerated neurological decline.